Including results for keros investor relations
Search only for kerx investor relations
The Investor Relations website contains information about Keros Therapeutics's business for stockholders, potential investors, and financial analysts.
Missing: kerx | Show results with:kerx
Corporate Presentation March 2024 · Hematology Franchise Investor Call Presentation December 2023 · KER-012 Investor Call Deck August 2023. Investors & Media.
Missing: kerx | Show results with:kerx
KERX - Keryx Pharmaceuticals Announces Upcoming Investor ...
br.advfn.com › KERX › share-news › ke...
KERX Keryx Biopharmaceuticals, Inc. (delisted). NASDAQ. 3,36. 0,00 (0,00 ... keryx.com within the Investor Relations section under “webcasts and presentations.
A high-level overview of Keryx Biopharmaceuticals, Inc. (KERX) stock. Stay up ... Akebia Keryx Merger Investor Presentation · SA TranscriptsThu, Jun. 28, 20185 ...
Missing: relations | Show results with:relations
IR Contacts. Company. Kiora Pharmaceuticals, Inc. 332 Encinitas Boulevard Suite 102. Encinitas, CA 92024. Investor Relations. Investors investors@kiorapharma.
Missing: kerx | Show results with:kerx
Keryx is headquartered in New York City. KERYX CONTACT: Lauren Fischer. Director - Investor Relations. Keryx Biopharmaceuticals, Inc. Tel: 212.531.5965.
Investor Relations. Overview · News & Events · Press ... As previously announced, Keryx shareholders are ... Reports on Form 10-Q, Current Reports on Form 8-K, the ...
KERX Keryx Biopharmaceuticals, Inc. Earnings Call Transcripts
seekingalpha.com › symbol › transcripts
(KERX) CEO Jodie Morrison on Q2 2018 Results - Earnings Call Transcript · SA TranscriptsWed, Aug. 08, 20188 Comments · Akebia Keryx Merger Investor Presentation.
Missing: relations | Show results with:relations
Who are Keryx Biopharmaceuticals's investors? Alpha Capital Partners, Foresite Capital, Great Point Partners, Kearny Venture Partners, and ProQuest Investments ...
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) institutional ownership structure shows current positions in the company by institutions and funds, as well as ...